HIV-1 infection-induced apoptotic microparticles inhibit human DCs via CD44.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 23160198.
- Also identified by DOI 10.1172/JCI64439 and PMC identifier 3533550.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Acute HIV-1 infection results in dysregulated immunity, which contributes to poor control of viral infection. DCs are key regulators of both adaptive and innate immune responses needed for controlling HIV-1, and we surmised that factors elicited during acute HIV-1 infection might impede DC function. We derived immature DCs from healthy donor peripheral blood monocytes and treated them with plasma from uninfected control donors and donors with acute HIV-1 infections. We found that the plasma from patients with HIV specifically inhibited DC function. This suppression was mediated by elevated apoptotic microparticles derived from dying cells during acute HIV-1 infection. Apoptotic microparticles bound to and inhibited DCs through the hyaluronate receptor CD44. These data suggest that targeting this CD44-mediated inhibition by apoptotic microparticles could be a novel strategy to potentiate DC activation of HIV-specific immunity.
Medical subject headings
- Apoptosis
- Cell-Derived Microparticles
- Dendritic Cells
- HIV Infections
- HIV-1
- Hyaluronan Receptors